USPTO serial 75634270
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jay H. Begler
JAY H BEGLER HARRIS BEACH & WILCOX530 FIFTH AVENEW YORK, NY 10036UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the diagnosis, treatment and prevention of transplant rejection and other autoimmune diseases including psoriasis, systemic lupus erythematosus, and rheumatoid arthritis | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 18, 2000 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Nov 18, 1999 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Nov 9, 1999 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 8, 1999 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 27, 1999 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 20, 1999 | CNEA | EXAMINER'S AMENDMENT MAILED | — |
| Jul 15, 1999 | DOCK | ASSIGNED TO EXAMINER | — |